It took three years, but this biotech may be quietly finding its footing as its innovative Provenge prostate-cancer fighter gains credibility. More
- ADVERTISEMENT
-
Sponsored By:
-
4 High-Fliers That Could Crash-Land Soon
Female Prison Guards Allegedly Aided Drug Ring
Reese Witherspoon Arrested for Disorderly Conduct
4 Funds to Harness the Awakening Bear
15 Dividend Stocks to Buy on the Cheap
Monday Apple Rumors: iMacs to Get Faster Chips This Summer
This Fund Can Triple Your Protection When the Fed Begins to Taper
Verizon Accused of Slowing Netflix Streaming
Tesla Owners Get Special Service on Recall
Now That Obesity Is Classified as a ‘Disease’ …
Utilities’ Sell-off Makes Them an Excellent Value
Wednesday Apple Rumors: ‘iPhone Lite’ to Resemble iPhone 5 -
Sponsored By:
- Poll of the Day
- Partners
- ADVERTISEMENT
- More Financial News







